(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EXTRA[NOT]ORDINARY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

EXTRA[NOT]ORDINARY

ST13

US500000098192187

Class

1, 5, 42, 45

Filing

98192187

Registration

7402053

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

05/28/2024

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 42, 45

Filing date

09/22/2023

Registration date

05/28/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/28/2024

Last transaction

05/28/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Valby, DK

Examiner

GULIANO, ROBERT N

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Genmab A/S

Representatives

Max Vern Amster, Rothstein & Ebenstein LLP

Technical classification

Nice Classes

Class 1Class 5Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemicalbiologicalbiotechnological preparationsantibodies and bi- and multispecific antibodies in the nature of monoclonal antibodies for in vitro and in vivo scientific research and development use with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancerautoimmune diseasesinflammatory disorders

Class 5

Pharmaceutical and veterinary preparationsincluding pharmaceutical preparations based on antibodies for the treatment of cancerautoimmune diseasesinflammatory disorders

Class 42

Medicalscientific and biological researchmedical and scientific research into antibodies and bi- and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these; chemical analysis; computer programmingprogramming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapyincluding scientific researchdevelopment and therapy with antibodies and bi- and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these

Class 45

Legal services related to the exploitation of patents and licensing of intellectual property in the field of medicine patents

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/28/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/28/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/12/2024

PUBO

PUBLISHED FOR OPPOSITION

03/12/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/21/2024

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

02/08/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

01/26/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/23/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/16/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/16/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/16/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/15/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/15/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

01/15/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/15/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/15/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/15/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/16/2023

GNRT

NON-FINAL ACTION E-MAILED

10/16/2023

CNRT

NON-FINAL ACTION WRITTEN

10/16/2023

DOCK

ASSIGNED TO EXAMINER

10/11/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/10/2023

NWAP

NEW APPLICATION ENTERED

09/26/2023

Continuous trademark protection

Get notified about every new filing that threatens EXTRA[NOT]ORDINARY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.